BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26428896)

  • 1. Long-term outcome of transendoscopic oesophageal mass ablation in dogs with Spirocerca lupi-associated oesophageal sarcoma.
    Shipov A; Kelmer G; Lavy E; Milgram J; Aroch I; Segev G
    Vet Rec; 2015 Oct; 177(14):365. PubMed ID: 26428896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful transendoscopic oesophageal mass ablation in two dogs with Spirocerca lupi associated oesophageal sarcoma.
    Yas E; Kelmer G; Shipov A; Ben-Oz J; Segev G
    J Small Anim Pract; 2013 Sep; 54(9):495-8. PubMed ID: 23647727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spirocerca lupi induced oesophageal neoplasia: Predictors of surgical outcome.
    Pazzi P; Kavkovsky A; Shipov A; Segev G; Dvir E
    Vet Parasitol; 2018 Jan; 250():71-77. PubMed ID: 29329628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spirocercosis-associated esophageal sarcomas in dogs. A retrospective study of 17 cases (1997-2003).
    Ranen E; Lavy E; Aizenberg I; Perl S; Harrus S
    Vet Parasitol; 2004 Jan; 119(2-3):209-21. PubMed ID: 14746980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developments in the therapy of spirocercosis-induced sarcoma.
    Dvir E
    Vet Rec; 2015 Oct; 177(14):363-4. PubMed ID: 26449905
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum acute phase protein concentrations in dogs with spirocercosis and their association with esophageal neoplasia - a prospective cohort study.
    Nivy R; Caldin M; Lavy E; Shaabon K; Segev G; Aroch I
    Vet Parasitol; 2014 Jun; 203(1-2):153-9. PubMed ID: 24656552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spirocercosis-associated pyothorax in dogs.
    Klainbart S; Mazaki-Tovi M; Auerbach N; Aizenberg I; Bruchim Y; Dank G; Lavy E; Aroch I; Harrus S
    Vet J; 2007 Jan; 173(1):209-14. PubMed ID: 16246607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful resolution of oesophageal spirocercosis in 20 dogs following daily treatment with oral doramectin.
    Lobetti R
    Vet J; 2012 Jul; 193(1):277-8. PubMed ID: 22000593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of selected growth factor expression in canine spirocercosis (Spirocerca lupi)-associated non-neoplastic nodules and sarcomas.
    Dvir E; Clift SJ
    Vet Parasitol; 2010 Dec; 174(3-4):257-66. PubMed ID: 20888695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum acute phase proteins in dogs with symptomatic esophageal spirocercosis.
    Mylonakis ME; Ceron JJ; Leontides L; Rallis TS; Koutinas AF
    Vet Parasitol; 2012 Nov; 190(1-2):191-5. PubMed ID: 22683300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma IL-8 concentrations are increased in dogs with spirocercosis.
    Dvir E; Mellanby RJ; Kjelgaard-Hansen M; Schoeman JP
    Vet Parasitol; 2012 Nov; 190(1-2):185-90. PubMed ID: 22770706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of milbemycin oxime against pre-adult Spirocerca lupi in experimentally infected dogs.
    Kok DJ; Schenker R; Archer NJ; Horak IG; Swart P
    Vet Parasitol; 2011 Apr; 177(1-2):111-8. PubMed ID: 21168275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum alkaline phosphatase activity is not a marker for neoplastic transformation of esophageal nodules in canine spirocercosis.
    Mukorera V; van der Merwe LL; Lavy E; Aroch I; Dvir E
    Vet Clin Pathol; 2011 Sep; 40(3):389-92. PubMed ID: 21790698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and quantification of Spirocerca lupi by HRM qPCR in fecal samples from dogs with spirocercosis.
    Rojas A; Segev G; Markovics A; Aroch I; Baneth G
    Parasit Vectors; 2017 Sep; 10(1):435. PubMed ID: 28927435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical differentiation between dogs with benign and malignant spirocercosis.
    Dvir E; Kirberger RM; Mukorera V; van der Merwe LL; Clift SJ
    Vet Parasitol; 2008 Aug; 155(1-2):80-8. PubMed ID: 18534758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor concentrations in dogs with spirocercosis.
    Mukorera V; Kirberger RM; Mabeta P; Dvir E
    J Vet Intern Med; 2013; 27(6):1642-5. PubMed ID: 24011385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant extradural spinal migration of Spirocerca lupi: four dogs.
    Du Plessis CJ; Keller N; Millward IR
    J Small Anim Pract; 2007 May; 48(5):275-8. PubMed ID: 17425698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of milbemycin oxime in a prophylactic anthelmintic programme to protect puppies, raised in an endemic area, against infection with Spirocerca lupi.
    Kok DJ; Williams EJ; Schenker R; Archer NJ; Horak IG
    Vet Parasitol; 2010 Dec; 174(3-4):277-84. PubMed ID: 20869809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spirocerca lupi infection in the dog: a review.
    van der Merwe LL; Kirberger RM; Clift S; Williams M; Keller N; Naidoo V
    Vet J; 2008 Jun; 176(3):294-309. PubMed ID: 17512766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oesophageal sarcomas in dogs: histological and clinical evaluation.
    Ranen E; Dank G; Lavy E; Perl S; Lahav D; Orgad U
    Vet J; 2008 Oct; 178(1):78-84. PubMed ID: 17804268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.